Anlotinib Plus S-1 for Patients with EGFR Mutation-Negative Advanced Squamous Cell Lung Cancer with PS Scores of 2â3 After Progression of Second-Line or Later-Line Treatment
Xie, Xiao-Hong, Wang, Fei, Lin, Xin-Qing, Qin, Yin-Yin, Xie, Zhan-Hong, Zhang, Jie-Xia, Ouyang, Ming, Zhou, Cheng-ZhiVolume:
Volume 12
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S278068
Date:
December, 2020
Fichier:
PDF, 996 KB
2020